R-CHOP vs CHOP Combined With Dose-Dense Rituximab for DLBCL
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Blood Advances
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
A Randomized Phase 2/3 Study of R-CHOP vs CHOP Combined With Dose-Dense Rituximab for DLBCL: The JCOG0601 Trial
Blood Adv 2021 Feb 23;5(4)984-993, K Ohmachi, T Kinoshita, K Tobinai, G Ogawa, T Mizutani, N Yamauchi, N Fukuhara, T Uchida, K Yamamoto, K Miyazaki, N Tsukamoto, S Iida, T Utsumi, I Yoshida, Y Imaizumi, T Tokunaga, S Yoshida, Y Masaki, T Murayama, Y Yakushijin, Y Suehiro, K Nosaka, N Dobashi, J Kuroda, Y Takamatsu, D Maruyama, K Ando, K Ishizawa, M Ogura, T Yoshino, T Hotta, K Tsukasaki, H NagaiFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.